{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:51:13Z","timestamp":1792644673157,"version":"4.5.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T00:00:00Z","timestamp":1391644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088193","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T22:07:19Z","timestamp":1391724439000},"page":"e88193","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":330,"title":["Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin"],"prefix":"10.1371","volume":"9","author":[{"given":"Cristina","family":"Federici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Caimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albino","family":"Cesolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariantonia","family":"Logozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"D'Ilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Lugini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Violante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Azzarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Majorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","article-title":"Melanoma biology and new targeted therapy","volume":"22","author":"V Gray-Schopfer","year":"2007","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cncr.22427","article-title":"Chemotherapy for metastatic melanoma: time for a change","volume":"109","author":"HJ Gogas","year":"2007","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.1999.17.9.2745","article-title":"Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma","volume":"17","author":"PB Chapman","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","article-title":"Management of cutaneous melanoma","volume":"351","author":"H Tsao","year":"2004","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2133.2001.04129.x","article-title":"Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells","volume":"144","author":"N Ichihashi","year":"2001","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics","volume":"1","author":"SR McWhinney","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref7","first-page":"35","article-title":"Cellular pharmacology of CisPt: perspectives on mechanisms of acquired resistance","volume":"2","author":"PA Andrews","year":"1990","journal-title":"Cancer cell"},{"key":"ref8","first-page":"1710","article-title":"Establishment and characterization of an in vitro model of acquired resistance to CisPt in a human testicular nonseminomatous germ cell line","volume":"52","author":"LR Kelland","year":"1992","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/onc.2011.426","article-title":"Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance","volume":"31","author":"W Li","year":"2012","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/cncr.2820710424","article-title":"Mechanism and modulation of resistance to chemotherapy in ovarian cancer","volume":"71","author":"R Perez","year":"1993","journal-title":"Cancer (Phila)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002800050967","article-title":"CisPt efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8\/0.7 CisPt-resistant variant","volume":"44","author":"Q Chau","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2796.2010.02225.x","article-title":"Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism","volume":"267","author":"S Fais","year":"2010","journal-title":"J Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/138161212799504911","article-title":"A rationale for the use of proton pump inhibitors as antineoplastic agents","volume":"18","author":"A De Milito","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.25009","article-title":"pH-dependent antitumour activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumour acidity","volume":"127","author":"A De Milito","year":"2010","journal-title":"Int J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00467-2","article-title":"Tumour acidity, ion trapping and chemotherapeutics. Acidic pH affects the distribution of chemotherapeutics agents in vitro","volume":"66","author":"BP Mahoney","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1073\/pnas.91.3.1128","article-title":"Intracellular pH and the control of multidrug resistance","volume":"91","author":"S Simon","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-2952(99)00021-0","article-title":"pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs","volume":"57","author":"N Raghunand","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6690455","article-title":"Enhancement of chemotherapy by manipulation of tumour pH","volume":"80","author":"N Raghunand","year":"1999","journal-title":"Br J Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1007521430236","article-title":"Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells","volume":"15","author":"Z Ouar","year":"1999","journal-title":"Cell Biol Toxicol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1158\/0008-5472.CAN-07-1805","article-title":"Targeting vacuolar H<sup>+<\/sup>-ATPases as a new strategy against cancer","volume":"15","author":"S Fais","year":"2007","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"C1015","DOI":"10.1152\/ajpcell.1993.265.4.C1015","article-title":"Vacuolar-type H(<sup>+<\/sup>)-ATPases are functionally expressed in plasma membranes of human tumour cells","volume":"265","author":"R Martinez-Zaguilan","year":"1993","journal-title":"Am J Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ijc.1418","article-title":"Elevated expression of vacuolar proton pump genes and cellular PH in CisPt resistance","volume":"93","author":"T Murakami","year":"2001","journal-title":"Int J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/djh305","article-title":"Effect of proton pump inhibitor pretreatment on resistance of solid tumours to cytotoxic drugs","volume":"96","author":"F Luciani","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1479-5876-9-221","article-title":"Lansoprazole as a rescue agent in chemoresistant tumours: a phase I\/II study in companion animals with spontaneously occurring tumours","volume":"28","author":"EP Spugnini","year":"2011","journal-title":"J Transl Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2217\/14796694.1.6.779","article-title":"Tumour acidity, chemoresistance and proton pump inhibitors","volume":"1","author":"A De Milito","year":"2005","journal-title":"Future Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.756.11.2","article-title":"Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells","volume":"11","author":"R Safaei","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/sj.bjc.6600861","article-title":"Reduced endocytosis and altered lysosome function in cisplatin resitant cell lines","volume":"88","author":"SS Chauhan","year":"2003","journal-title":"Br J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","article-title":"Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells","volume":"4","author":"R Safaei","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20011624","article-title":"Induction of lymphocyte apoptosis by tumour cell secretion of FasL-bearing microvesicles","volume":"195","author":"G Andreola","year":"2002","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"H Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","article-title":"Microenvironmental pH is a key factor for exosome traffic in tumour cells","volume":"284","author":"I Parolini","year":"2009","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","article-title":"B lymphocytes secrete antigen-presenting vesicles","volume":"183","author":"G Raposo","year":"1996","journal-title":"J Exp Med"},{"key":"ref33","first-page":"879","article-title":"Exosomal-like vesicles are present in human blood plasma","volume":"17","author":"MP Caby","year":"2005","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchromb.2006.03.063","article-title":"Specific determination of intact CisPt and monohydrated CisPt in human plasma and culture medium ultra-filtrates using HPLC on-line with inductively coupled plasma mass spectrometry","volume":"837","author":"DN Bell","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref35","first-page":"59","article-title":"Protocols for screening chemical agents and natural products against animal tumours and natural other biological systems","volume":"3","author":"RI Geran","year":"1972","journal-title":"Cancer Chemother Rep"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e5219","DOI":"10.1371\/journal.pone.0005219","article-title":"High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients","volume":"4","author":"M Logozzi","year":"2009","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-06-4095","article-title":"Proton pump inhibitors induce apoptosis of human B-cell tumours through a caspase-independent mechanism involving reactive oxygen species","volume":"67","author":"A De Milito","year":"2007","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchromb.2006.03.063","article-title":"Specific determination of intact cisplatin and monohydrated cisplatin in human plasma and culture medium ultrafiltrates using HPLC on-line with inductively coupled plasma mass spectrometry","volume":"837","author":"DN Bell","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-4347(00)00498-9","article-title":"Speciation of platinum compounds: a review of recent applications in studies of platinum anticancer drugs","volume":"751","author":"RR Barefoot","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/1097-0215(20000815)87:4<569::AID-IJC17>3.0.CO;2-U","article-title":"Murine granulocytes control human tumour growth in SCID mice","volume":"87","author":"F Lozupone","year":"2000","journal-title":"Int J Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drup.2009.09.001","article-title":"Novel strategies for reversing platinum resistance","volume":"12","author":"MM Shahzad","year":"2009","journal-title":"Drug Resist Updat"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/onc.2012.183","article-title":"LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumour microenvironment through inhibiting activity of V-ATPase proton pump","volume":"32","author":"S Fan","year":"2013","journal-title":"Oncogene"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s007750000153","article-title":"New insights in the cellular processing of platinum antitumour compounds, using fluorophore-labeled platinum complexes and digital fluorescence microscopy","volume":"5","author":"C Molenaar","year":"2000","journal-title":"J Biol Inorg Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/14656566.6.7.1049","article-title":"Proton pump inhibitors may reduce tumour resistance","volume":"6","author":"A De Milito","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"ref45","unstructured":"Larsson H, Mattson H, Sundell G, Carlsson E (1985) Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo. Scand J Gastroenterol Suppl 108: 23\u201335."},{"key":"ref46","first-page":"9","article-title":"Body fluid derived exosomes as a novel template for clinical diagnostics","volume":"8","author":"S Keller","year":"2011","journal-title":"J Transl Med"},{"key":"ref47","first-page":"308","article-title":"Analytical and Pharmacokinetic studies of CisPt-based antitumour agents in biological fluids","volume":"5","author":"S Caroli","year":"1988","journal-title":"Trace Element Analytical Chemistry in Medicine and Biology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/138161212799504911","article-title":"A rationale for the use of proton pump inhibitors as antineoplastic agents","volume":"18","author":"A De Milito","year":"2012","journal-title":"Curr Pharm Des"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T09:22:36Z","timestamp":1688980956000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088193"}},"subtitle":[],"editor":[{"given":"Irina V.","family":"Lebedeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,6]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088193","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,6]]}}}